{"DataElement":{"publicId":"3192262","version":"1","preferredName":"Hemoglobinopathy Laboratory Procedure Outcome","preferredDefinition":"Information related to the outcome of the hemoglobinopathy.","longName":"3202922v1.0:3190138v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3202922","version":"1","preferredName":"Hemoglobinopathy Laboratory Procedure Outcome","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action.[manually curated]","longName":"3192150v1.0:2224045v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3192150","version":"1","preferredName":"Hemoglobinopathy Laboratory Procedure","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C3092:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C58BE6A-5B81-4945-E040-BB89AD437879","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA","dateModified":"2011-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E72583C-8C10-CDD7-E040-BB89AD43275F","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3190138","version":"1","preferredName":"Hemoglobinopathy Laboratory Procedure Outcome","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"3190138v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other result","valueDescription":"Other Outcome","ValueMeaning":{"publicId":"3190139","version":"1","preferredName":"Other Outcome","longName":"3190139","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Outcome; a phenomenon that follows and is caused by some previous phenomenon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BD0C-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BC5911C-BD25-9C43-E040-BB89AD432688","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"ONEDATA","dateModified":"2011-02-08","deletedIndicator":"No"},{"value":"Hemoglobin / sickle cell disease","valueDescription":"Hemoglobin And/Or Sickle Cell Disease","ValueMeaning":{"publicId":"3190140","version":"1","preferredName":"Hemoglobin And/Or Sickle Cell Disease","longName":"3190140","preferredDefinition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.: Used to indicate that either or both of two items or options: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin","conceptCode":"C16676","definition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BD33-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BC5911C-BD4C-9C43-E040-BB89AD432688","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"ONEDATA","dateModified":"2011-02-08","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Hemoglobin F Measurement And Hemoglobin A Measurement","ValueMeaning":{"publicId":"3190150","version":"1","preferredName":"Hemoglobin F Measurement And Hemoglobin A Measurement","longName":"3190150","preferredDefinition":"The determination of the amount of hemoglobin F present in a sample.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The determination of the amount of hemoglobin A present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin F Measurement","conceptCode":"C92262","definition":"The determination of the amount of hemoglobin F present in a sample.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemoglobin A Measurement","conceptCode":"C92258","definition":"The determination of the amount of hemoglobin A present in a sample.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BE5D-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BC5911C-BE76-9C43-E040-BB89AD432688","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"ONEDATA","dateModified":"2011-02-08","deletedIndicator":"No"},{"value":"Alpha thalassemia identified by rapid screen testing,not further quantified by DNA testing","valueDescription":"Rapid Screening Method for Alpha Thalassemia","ValueMeaning":{"publicId":"3190297","version":"1","preferredName":"Rapid Screening Method for Alpha Thalassemia","longName":"3190297","preferredDefinition":"Screening techniques for alpha thalassemia that use melting curve analysis of PCR products generated from the alpha globin alleles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rapid Screening Method for Alpha Thalassemia","conceptCode":"C95541","definition":"Screening techniques for alpha thalassemia that use melting curve analysis of PCR products generated from the alpha globin alleles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BDC458A-5466-BFF4-E040-BB89AD430CFB","latestVersionIndicator":"Yes","beginDate":"2011-02-09","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BDC458A-547F-BFF4-E040-BB89AD430CFB","beginDate":"2011-02-09","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-09","modifiedBy":"ONEDATA","dateModified":"2011-02-09","deletedIndicator":"No"},{"value":"Alpha thalassemia silent carrier","valueDescription":"Alpha Thalassemia Silent Carrier","ValueMeaning":{"publicId":"3190142","version":"1","preferredName":"Alpha Thalassemia Silent Carrier","longName":"3190142","preferredDefinition":"A condition in which a person has reduced protein production from one of the four alpha-globin alleles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha Thalassemia Silent Carrier","conceptCode":"C95536","definition":"A condition in which a person has reduced protein production from one of the four alpha-globin alleles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BD7B-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E69A195-DBF3-5FEC-E040-BB89AD4367ED","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-13","modifiedBy":"ONEDATA","dateModified":"2011-03-13","deletedIndicator":"No"},{"value":"Alpha thalassemia trait","valueDescription":"Alpha Thalassemia Trait","ValueMeaning":{"publicId":"3190143","version":"1","preferredName":"Alpha Thalassemia Trait","longName":"3190143","preferredDefinition":"A condition in which a person has reduced protein production from two of the four alpha-globin alleles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha Thalassemia Trait","conceptCode":"C95535","definition":"A condition in which a person has reduced protein production from two of the four alpha-globin alleles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BDA0-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E69A195-DC07-5FEC-E040-BB89AD4367ED","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-13","modifiedBy":"ONEDATA","dateModified":"2011-03-13","deletedIndicator":"No"},{"value":"Beta thalassemia plus structural variants","valueDescription":"Beta Thalassemia Plus Structural Variants","ValueMeaning":{"publicId":"3190146","version":"1","preferredName":"Beta Thalassemia Plus Structural Variants","longName":"3190146","preferredDefinition":"A heterozygous state in which a person has a mutation in a beta globin allele causing beta thalassemia, together with other structural variants in the other allele.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beta Thalassemia Plus Structural Variants","conceptCode":"C95538","definition":"A heterozygous state in which a person has a mutation in a beta globin allele causing beta thalassemia, together with other structural variants in the other allele.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BE0F-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E69A195-DC1B-5FEC-E040-BB89AD4367ED","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-13","modifiedBy":"ONEDATA","dateModified":"2011-03-13","deletedIndicator":"No"},{"value":"Hemoglobin trait","valueDescription":"Hemoglobin Trait","ValueMeaning":{"publicId":"3190147","version":"1","preferredName":"Hemoglobin Trait","longName":"3190147","preferredDefinition":"A condition in which a person is heterozygous for a globin gene, with a one normal allele and one defective allele.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Trait","conceptCode":"C95534","definition":"A condition in which a person is heterozygous for a globin gene, with a one normal allele and one defective allele.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BE34-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E69A195-DC2F-5FEC-E040-BB89AD4367ED","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-13","modifiedBy":"ONEDATA","dateModified":"2011-03-13","deletedIndicator":"No"},{"value":"Alpha thalassemia, severe disease","valueDescription":"Hemoglobin H Disease","ValueMeaning":{"publicId":"3204272","version":"1","preferredName":"Hemoglobin H Disease","longName":"3204272","preferredDefinition":"A severe form of alpha thalassemia that results from reduced protein production from three of the four alpha-globin genes. Clinically it is characterized by chronic hemolytic anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin H Disease","conceptCode":"C95504","definition":"A form of alpha thalassemia that results from reduced protein production from three of the four alpha-globin genes. Clinically it is characterized by chronic hemolytic anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E9CBBC9-E1EB-A1D9-E040-BB89AD430197","latestVersionIndicator":"Yes","beginDate":"2011-03-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E9CBBC9-E204-A1D9-E040-BB89AD430197","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-16","modifiedBy":"ONEDATA","dateModified":"2011-03-16","deletedIndicator":"No"},{"value":"Homozygous hemoglobin C or E, non-disease","valueDescription":"Homozygous Hemoglobin C or E, Non-disease","ValueMeaning":{"publicId":"3190144","version":"1","preferredName":"Homozygous Hemoglobin C or E, Non-disease","longName":"3190144","preferredDefinition":"A state in which both beta-globin alleles code for a C or E variant but which leads to such minor changes to the hemoglobin that it does not cause disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Homozygous Hemoglobin C or E, Non-Disease","conceptCode":"C95537","definition":"A state in which both beta-globin alleles code for a C or E variant but which leads to such minor changes to the hemoglobin that it does not cause disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BDC5-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E9CBBC9-E218-A1D9-E040-BB89AD430197","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-16","modifiedBy":"ONEDATA","dateModified":"2011-03-16","deletedIndicator":"No"},{"value":"Sickle beta thalassemia","valueDescription":"Sickle Beta Thalassemia","ValueMeaning":{"publicId":"3204273","version":"1","preferredName":"Sickle Beta Thalassemia","longName":"3204273","preferredDefinition":"A heterozygous state in which a person has a hemoglobin S allele along with a beta-thalassemia allele. The severity of the condition is determined to a large extent by the quantity of normal hemoglobin produced by the beta-thalassemia gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Beta Thalassemia","conceptCode":"C95539","definition":"A heterozygous state in which a person has a hemoglobin S allele along with a beta-thalassemia allele. The severity of the condition is determined to a large extent by the quantity of normal hemoglobin produced by the beta-thalassemia gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E9CBBC9-E222-A1D9-E040-BB89AD430197","latestVersionIndicator":"Yes","beginDate":"2011-03-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E9CBBC9-E23B-A1D9-E040-BB89AD430197","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-16","modifiedBy":"ONEDATA","dateModified":"2011-03-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3190137","version":"1","preferredName":"Hemoglobinopathy Laboratory Procedure Outcome","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C3092:C25294:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BCE5-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"ONEDATA","dateModified":"2011-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BC5911C-BCF6-9C43-E040-BB89AD432688","latestVersionIndicator":"Yes","beginDate":"2011-02-08","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-08","modifiedBy":"KUMMEROA","dateModified":"2012-04-23","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3191905","version":"1","longName":"2007r1:Cord Blood Unit -SCTOD Data Requirements","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is hemoglobinopathy test","type":"Preferred Question Text","description":"What is hemoglobinopathy testing result?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C697266-A95C-5470-E040-BB89AD43394A","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-16","modifiedBy":"KUMMEROA","dateModified":"2021-08-06","changeDescription":". 2021-8-6 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}